Arno Therapeutics Inc (ARNI) Financial Statements (2024 and earlier)

Company Profile

Business Address 200 ROUTE 31 NORTH
FLEMINGTON, NJ 08822
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2016
MRQ
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 66,9887,948,43626,774,20310,943,437
Cash and cash equivalents 66,9887,948,43626,774,20310,943,437
Prepaid expense and other current assets203,516
Other undisclosed current assets 260,694258,04686,266 
Total current assets: 327,6828,206,48226,860,46911,146,953
Noncurrent Assets
Property, plant and equipment 23,10330,73011,72024,837
Deposits noncurrent assets 10,45510,45510,45510,455
Deferred costs    1,709,530
Total noncurrent assets: 33,55841,18522,1751,744,822
TOTAL ASSETS: 361,2408,247,66726,882,64412,891,775
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 1,010,215742,4482,941,9981,553,154
Accounts payable 1,010,215742,4482,941,9981,553,154
Debt 3,8533,322  
Deferred revenue and credits 1,9101,0487,79712,711
Due to related parties   26,03928,268
Other undisclosed current liabilities 3,214,5991,410,293925,2551,652,159
Total current liabilities: 4,230,5772,157,1113,901,0893,246,292
Noncurrent Liabilities
Long-term debt and lease obligation 4,0707,923  
Capital lease obligations 4,0707,923  
Liabilities, other than long-term debt 4,750,6876,671,52435,864,88121,420,276
Derivative instruments and hedges, liabilities 4,750,6876,671,52435,864,88121,420,276
Other undisclosed noncurrent liabilities    491,039
Total noncurrent liabilities: 4,754,7576,679,44735,864,88121,911,315
Total liabilities: 8,985,3348,836,55839,765,97025,157,607
Equity
Equity, attributable to parent, including: (8,624,094)(588,891)(12,883,326)(12,265,832)
Common stock 5,4695,4695,4653,611
Additional paid in capital 84,665,39081,192,63076,668,96637,631,339
Accumulated deficit (93,294,953)   
Warrants and rights outstanding    12,430,525
Other undisclosed equity, attributable to parent  (81,786,990)(89,557,757)(62,331,307)
Total equity: (8,624,094)(588,891)(12,883,326)(12,265,832)
TOTAL LIABILITIES AND EQUITY: 361,2408,247,66726,882,64412,891,775

Income Statement (P&L) (USD)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Operating expenses (13,411,811)(21,493,326)(16,940,549)(10,835,801)
Operating loss: (13,411,811)(21,493,326)(16,940,549)(10,835,801)
Nonoperating income (expense) 1,903,84829,264,093(22,716,426)(3,551,981)
Debt instrument, convertible, beneficial conversion feature  7,548,500  
Other nonoperating income (expense) 1,924,59329,222,282(4,165,006)2,801,199
Interest and debt expense (28,403)(143)(2,174,244)(6,361,029)
Income (loss) from continuing operations: (11,536,366)7,770,624(41,831,219)(20,748,811)
Income (loss) before gain (loss) on sale of properties: (11,536,366)7,770,624(41,831,219)(20,748,811)
Net income (loss): (11,536,366)7,770,624(41,831,219)(20,748,811)
Other undisclosed net income attributable to parent 28,4031432,174,2446,361,029
Net income (loss) available to common stockholders, basic: (11,507,963)7,770,767(39,656,975)(14,387,782)
Dilutive securities, effect on basic earnings per share   39,775,318 
Net income (loss) available to common stockholders, diluted: (11,507,963)7,770,767118,343(14,387,782)

Comprehensive Income (USD)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss): (11,536,366)7,770,624(41,831,219)(20,748,811)
Comprehensive income (loss), net of tax, attributable to parent: (11,536,366)7,770,624(41,831,219)(20,748,811)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: